BRPI0911161A2 - derivado de piridazinona - Google Patents

derivado de piridazinona

Info

Publication number: BRPI0911161A2
Authority: BR; Brazil
Prior art keywords: pyridazinone derivative; pyridazinone; derivative
Prior art date: 2008-04-21

Application number

BRPI0911161A

Other languages

English (en)

Inventor

Andree Blaukat

Dieter Dorsch

Frank Stieber

Oliver Schadt

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-21

Filing date

2009-03-24

Publication date

2015-10-06

2009-03-24 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2015-10-06 Publication of BRPI0911161A2 publication Critical patent/BRPI0911161A2/pt

2020-02-11 Publication of BRPI0911161B1 publication Critical patent/BRPI0911161B1/pt

2021-05-25 Publication of BRPI0911161B8 publication Critical patent/BRPI0911161B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0911161A 2008-04-21 2009-03-24 derivados de piridazinona e seu processo de preparação BRPI0911161B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102008019907.9		2008-04-21
DE102008019907A DE102008019907A1 (de)	2008-04-21	2008-04-21	Pyridazinonderivate
PCT/EP2009/002137 WO2009129905A1 (de)	2008-04-21	2009-03-24	Pyridazinonderivate

Publications (3)

Publication Number	Publication Date
BRPI0911161A2 true BRPI0911161A2 (pt)	2015-10-06
BRPI0911161B1 BRPI0911161B1 (pt)	2020-02-11
BRPI0911161B8 BRPI0911161B8 (pt)	2021-05-25

Family

ID=40639931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0911161A BRPI0911161B8 (pt)	2008-04-21	2009-03-24	derivados de piridazinona e seu processo de preparação

Country Status (22)

Country	Link
US (1)	US8604036B2 (pt)
EP (1)	EP2280962B1 (pt)
JP (1)	JP5576358B2 (pt)
KR (1)	KR20100137564A (pt)
CN (1)	CN102015694A (pt)
AR (1)	AR071208A1 (pt)
AU (1)	AU2009240346B2 (pt)
BR (1)	BRPI0911161B8 (pt)
CA (1)	CA2721858C (pt)
CY (1)	CY1113443T1 (pt)
DE (1)	DE102008019907A1 (pt)
DK (1)	DK2280962T5 (pt)
EA (1)	EA018362B1 (pt)
ES (1)	ES2394147T3 (pt)
HR (1)	HRP20120884T1 (pt)
IL (1)	IL208336A (pt)
MX (1)	MX2010011454A (pt)
PL (1)	PL2280962T3 (pt)
PT (1)	PT2280962E (pt)
SI (1)	SI2280962T1 (pt)
WO (1)	WO2009129905A1 (pt)
ZA (1)	ZA201008330B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
DE102007032507A1 (de)	2007-07-12	2009-04-02	Merck Patent Gmbh	Pyridazinonderivate
DE102007038957A1 (de) *	2007-08-17	2009-02-19	Merck Patent Gmbh	6-Thioxo-pyridazinderivate
DE102007061963A1 (de) *	2007-12-21	2009-06-25	Merck Patent Gmbh	Pyridazinonderivate
DE102008019907A1 (de)	2008-04-21	2009-10-22	Merck Patent Gmbh	Pyridazinonderivate
DE102008028905A1 (de) *	2008-06-18	2009-12-24	Merck Patent Gmbh	3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
DE102008037790A1 (de) *	2008-08-14	2010-02-18	Merck Patent Gmbh	Bicyclische Triazolderivate
SI2361250T1 (sl)	2008-12-22	2013-12-31	Merck Patent Gmbh	Nove polimorfne oblike 6-(1-metil-1h-pirazol-4-il)-2-(3-(5-(2-morfolin-4-il-etoksi)-pirimidin- 2-il)-benzil)-2h-piridazin-3-on dihidrogenfosfata in postopki za proizvodnjo le-tega
CN102532126B (zh) *	2012-02-10	2014-06-18	贵州大学	2-取代-4-氯-5-[5-取代胺基-2-(1,3,4-噻二唑基)-巯基]-3(2h)-哒嗪酮类衍生物及其制备方法和用途
US20190248765A1 (en) *	2016-10-26	2019-08-15	Proteostasis Therapeutics, Inc.	Compounds, compositions, and methods for increasing cftr activity
CN111465602B (zh)	2017-10-17	2023-05-23	帕劳制药有限公司	4-氨基嘧啶化合物的合成
CN108752322A (zh) *	2018-09-12	2018-11-06	广州新民培林医药科技有限公司	一种新型Tepotinib衍生物和制备方法及其在抗肿瘤药物中的应用
SMT202300355T1 (it)	2018-11-06	2024-01-10	Edgewise Therapeutics Inc	Composti di piridazinone e loro usi
CN113272280A (zh)	2018-11-06	2021-08-17	艾知怀斯治疗学公司	哒嗪酮化合物及其用途
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
US20240124436A1 (en)	2019-11-01	2024-04-18	Unimatec Co., Ltd.	Fluorine-containing pyrimidine compound and method for producing same

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5795964A (en)	1980-12-04	1982-06-15	Morishita Seiyaku Kk	Preparation of 2-substituted-3(2h)-pyridazinone derivative
US4397854A (en)	1981-05-14	1983-08-09	Warner-Lambert Company	Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
AU691673B2 (en)	1994-11-14	1998-05-21	Dow Agrosciences Llc	Pyridazinones and their use as fungicides
US5635494A (en)	1995-04-21	1997-06-03	Rohm And Haas Company	Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
DE19604388A1 (de)	1996-02-07	1997-08-14	Merck Patent Gmbh	Arylalkyl-diazinone
HUP9901155A3 (en)	1996-02-13	2003-04-28	Astrazeneca Ab	Quinazoline derivatives as vegf inhibitors
ATE211134T1 (de)	1996-03-05	2002-01-15		4-anilinochinazolin derivate
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
JPH10259176A (ja)	1997-03-17	1998-09-29	Japan Tobacco Inc	血管新生阻害作用を有する新規アミド誘導体及びその用途
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
ID24166A (id)	1997-11-19	2000-07-13	Kowa Co	Turunan piridazin baru dan obat-obatan yang mengandung hal yang sama sebagai ramuan efektif
TWI241295B (en) *	1998-03-02	2005-10-11	Kowa Co	Pyridazine derivative and medicine containing the same as effect component
AU756275B2 (en) *	1998-08-14	2003-01-09	Nihon Nohyaku Co., Ltd.	Pyridazinone derivatives
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
AUPQ462299A0 (en) *	1999-12-13	2000-01-13	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
US6242461B1 (en) *	2000-01-25	2001-06-05	Pfizer Inc.	Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
CN1431999A (zh)	2000-05-31	2003-07-23	阿斯特拉曾尼卡有限公司	具有血管损伤活性的吲哚衍生物
KR20030014425A (ko)	2000-07-07	2003-02-17	앤지오젠 파마슈티칼스 리미티드	혈관 손상제인 콜치놀 유도체
SK52003A3 (en)	2000-07-07	2003-07-01	Angiogene Pharm Ltd	Colchinol derivatives as angiogenesis inhibitors, method for their preparation and pharmaceutical composition comprising the same
CZ2004516A3 (cs) *	2001-10-31	2004-08-18	Merckápatentágmbh	Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
EP1572693A1 (en) *	2002-12-20	2005-09-14	Pharmacia Corporation	Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
JP2007516180A (ja)	2003-07-02	2007-06-21	スゲン，インコーポレイティド	ｃ−Ｍｅｔ阻害薬としてのアリールメチルトリアゾロおよびイミダゾピラジン類
US7959919B2 (en) *	2003-11-19	2011-06-14	Novelmed Therapeutics, Inc.	Method of inhibiting factor B-mediated complement activation
US20070015771A1 (en) *	2004-07-29	2007-01-18	Threshold Pharmaceuticals, Inc.	Lonidamine analogs
US20070043057A1 (en) *	2005-02-09	2007-02-22	Threshold Pharmaceuticals, Inc.	Lonidamine analogs
TW200612918A (en)	2004-07-29	2006-05-01	Threshold Pharmaceuticals Inc	Lonidamine analogs
WO2007044796A2 (en)	2005-10-11	2007-04-19	Nps Pharmaceuticals, Inc.	Pyridazinone compounds as calcilytics
WO2007064797A2 (en)	2005-11-30	2007-06-07	Vertex Pharmaceuticals Incorporated	Inhibitors of c-met and uses thereof
DE102005057924A1 (de) *	2005-12-05	2007-06-06	Merck Patent Gmbh	Pyridazinonderivate
UA98297C2 (en) *	2005-12-21	2012-05-10	Янссен Фармацевтика, Н.В.	Triazolopyridazines as tyrosine kinase modulators
WO2007130383A2 (en)	2006-04-28	2007-11-15	Northwestern University	Compositions and treatments using pyridazine compounds and secretases
NL2000613C2 (nl)	2006-05-11	2007-11-20	Pfizer Prod Inc	Triazoolpyrazinederivaten.
GB0610680D0 (en) *	2006-05-31	2006-07-12	Istituto Di Ricerche D Biolog	Therapeutic compounds
PE20080403A1 (es)	2006-07-14	2008-04-25	Amgen Inc	Derivados heterociclicos fusionados y metodos de uso
DE102006037478A1 (de) *	2006-08-10	2008-02-14	Merck Patent Gmbh	2-(Heterocyclylbenzyl)-pyridazinonderivate
US7737149B2 (en)	2006-12-21	2010-06-15	Astrazeneca Ab	N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
US8314087B2 (en) *	2007-02-16	2012-11-20	Amgen Inc.	Nitrogen-containing heterocyclyl ketones and methods of use
DE102007026341A1 (de) *	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
DE102007032507A1 (de) *	2007-07-12	2009-04-02	Merck Patent Gmbh	Pyridazinonderivate
TW200922584A (en)	2007-10-16	2009-06-01	Novartis Ag	Organic compounds
CA2703653A1 (en)	2007-10-25	2009-04-30	Astrazeneca Ab	Pyridine and pyrazine derivatives -083
KR20100084516A (ko) *	2007-10-31	2010-07-26	닛산 가가쿠 고교 가부시키 가이샤	피리다지논 유도체 및 이의 ｐ2ｘ7 수용체 억제제로서의 용도
JP5769970B2 (ja)	2007-11-16	2015-08-26	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ベンゾモルファン及び関連骨格のアリール−及びヘテロアリールカルボニル誘導体、かかる化合物を含有する医薬及びこれらの使用
AU2008339572B2 (en)	2007-12-21	2012-05-10	Astrazeneca Ab	Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
RU2495878C2 (ru)	2007-12-21	2013-10-20	Ф.Хоффманн-Ля Рош Аг	Гетероциклические антивирусные соединения
EP2234999A1 (en)	2007-12-21	2010-10-06	F. Hoffmann-La Roche AG	Heteroaryl derivatives as orexin receptor antagonists
GB0725059D0 (en)	2007-12-21	2008-01-30	Syngenta Participations Ag	Novel pyridazine derivatives
US8202996B2 (en)	2007-12-21	2012-06-19	Bristol-Myers Squibb Company	Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
EP2072506A1 (de)	2007-12-21	2009-06-24	Bayer CropScience AG	Thiazolyloxyphenylamidine oder Thiadiazolyloxyphenylamidine und deren Verwendung als Fungizide
CL2008003785A1 (es)	2007-12-21	2009-10-09	Du Pont	Compuestos derivados de piridazina; composiciones herbicidas que comprenden a dichos compuestos; y método para controlar el crecimiento de la vegetación indeseada.
PE20091339A1 (es)	2007-12-21	2009-09-26	Glaxo Group Ltd	Derivados de oxadiazol con actividad sobre receptores s1p1
UA101963C2 (en)	2007-12-21	2013-05-27	Палау Фарма, С.А.	4-amino-pyrimidine derivatives
DE102007061963A1 (de) *	2007-12-21	2009-06-25	Merck Patent Gmbh	Pyridazinonderivate
US7816540B2 (en)	2007-12-21	2010-10-19	Hoffmann-La Roche Inc.	Carboxyl- or hydroxyl-substituted benzimidazole derivatives
TW200930375A (en)	2007-12-21	2009-07-16	Exelixis Inc	Benzofuropyrimidinones
EP2242483B1 (en)	2007-12-21	2013-02-20	Synthon B.V.	Raloxifene composition
CN101538245B (zh) *	2008-03-18	2011-02-16	中国科学院上海药物研究所	一类哒嗪酮类化合物及其制备方法和制备药物的用途
DE102008019907A1 (de)	2008-04-21	2009-10-22	Merck Patent Gmbh	Pyridazinonderivate
EP2328586A2 (en) *	2008-05-20	2011-06-08	Cephalon, Inc.	Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
DE102008028905A1 (de) *	2008-06-18	2009-12-24	Merck Patent Gmbh	3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
US8487094B2 (en) *	2008-07-25	2013-07-16	Boehringer Ingelheim International Gmbh	Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
WO2010113986A1 (ja) *	2009-03-30	2010-10-07	住友化学株式会社	ピリダジノン化合物の有害節足動物防除用途
AR082590A1 (es) *	2010-08-12	2012-12-19	Hoffmann La Roche	Inhibidores de la tirosina-quinasa de bruton

2008
- 2008-04-21 DE DE102008019907A patent/DE102008019907A1/de not_active Withdrawn
2009
- 2009-03-24 KR KR1020107025412A patent/KR20100137564A/ko not_active Ceased
- 2009-03-24 PL PL09734854T patent/PL2280962T3/pl unknown
- 2009-03-24 EP EP09734854A patent/EP2280962B1/de active Active
- 2009-03-24 DK DK09734854.4T patent/DK2280962T5/da active
- 2009-03-24 CA CA2721858A patent/CA2721858C/en active Active
- 2009-03-24 US US12/988,666 patent/US8604036B2/en active Active
- 2009-03-24 SI SI200930411T patent/SI2280962T1/sl unknown
- 2009-03-24 PT PT97348544T patent/PT2280962E/pt unknown
- 2009-03-24 ES ES09734854T patent/ES2394147T3/es active Active
- 2009-03-24 AU AU2009240346A patent/AU2009240346B2/en not_active Ceased
- 2009-03-24 BR BRPI0911161A patent/BRPI0911161B8/pt not_active IP Right Cessation
- 2009-03-24 CN CN2009801141150A patent/CN102015694A/zh active Pending
- 2009-03-24 JP JP2011505385A patent/JP5576358B2/ja not_active Expired - Fee Related
- 2009-03-24 EA EA201001648A patent/EA018362B1/ru not_active IP Right Cessation
- 2009-03-24 MX MX2010011454A patent/MX2010011454A/es active IP Right Grant
- 2009-03-24 WO PCT/EP2009/002137 patent/WO2009129905A1/de active Application Filing
- 2009-03-24 HR HRP20120884AT patent/HRP20120884T1/hr unknown
- 2009-04-17 AR ARP090101359A patent/AR071208A1/es not_active Application Discontinuation
2010
- 2010-09-21 IL IL208336A patent/IL208336A/en active IP Right Grant
- 2010-11-19 ZA ZA2010/08330A patent/ZA201008330B/en unknown
2012
- 2012-12-07 CY CY20121101191T patent/CY1113443T1/el unknown

Also Published As

Publication number	Publication date
EP2280962A1 (de)	2011-02-09
IL208336A0 (en)	2010-12-30
PT2280962E (pt)	2012-12-17
DK2280962T3 (da)	2012-11-19
KR20100137564A (ko)	2010-12-30
PL2280962T3 (pl)	2013-02-28
JP5576358B2 (ja)	2014-08-20
CA2721858C (en)	2016-07-19
ZA201008330B (en)	2011-09-28
ES2394147T3 (es)	2013-01-22
EP2280962B1 (de)	2012-10-03
EA018362B1 (ru)	2013-07-30
CN102015694A (zh)	2011-04-13
AU2009240346A1 (en)	2009-10-29
HRP20120884T1 (hr)	2012-11-30
CY1113443T1 (el)	2016-06-22
DK2280962T5 (da)	2013-09-16
WO2009129905A1 (de)	2009-10-29
BRPI0911161B8 (pt)	2021-05-25
IL208336A (en)	2016-07-31
AU2009240346B2 (en)	2013-10-10
US20110034474A1 (en)	2011-02-10
JP2011518202A (ja)	2011-06-23
AR071208A1 (es)	2010-06-02
MX2010011454A (es)	2010-12-21
CA2721858A1 (en)	2009-10-29
DE102008019907A1 (de)	2009-10-22
US8604036B2 (en)	2013-12-10
EA201001648A1 (ru)	2011-06-30
SI2280962T1 (sl)	2013-01-31
BRPI0911161B1 (pt)	2020-02-11

Publication	Publication Date	Title
CY2022017I1 (el)	2023-01-05	Παραγωγα πυριδαζινονης
FR24C1047I1 (fr)	2025-01-10	Derive de 4-pyrimidinesulfamide
BRPI0923497A2 (pt)	2019-09-24	derivados de piridazinona
EP2376493A4 (en)	2012-05-30	DIHYDROPYRIMIDOPYRIMIDINDERIVAT
BRPI0911161A2 (pt)	2015-10-06	derivado de piridazinona
EP2380877A4 (en)	2012-06-27	PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
BRPI0812247A2 (pt)	2015-06-16	Derivados de piridazinona
EP2226315A4 (en)	2012-01-25	2-aminoquinazoline DERIVATIVE
EP2213673A4 (en)	2011-09-07	PYRIDONE-SUBSTITUTED DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE
EP2393360A4 (en)	2012-08-15	PYRIDAZINONE COMPOUNDS
EP2336132A4 (en)	2012-03-21	MORPHOLINPURINDERIVAT
BRPI0821743A2 (pt)	2015-09-22	derivados de piridazinona
DK2340021T3 (da)	2012-12-10	Substituerede pyrrolidin-2-carboxamider
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
BRPI0921327A2 (pt)	2015-08-25	Combinação de herbicida-protetor
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
EP2344471A4 (en)	2012-05-30	7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate
BRPI0913234A2 (pt)	2016-01-19	derivados de tiazolilpiperidina
BRPI0915562A2 (pt)	2016-01-26	tamis melhorado
BRPI0915442A2 (pt)	2017-06-27	tamis melhorado
BRPI0922652A2 (pt)	2015-08-11	Derivados de quinazolinamida
ATE534634T1 (de)	2011-12-15	2-phenyl-4-cyclopropyl-pyrimidinderivate

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-03-26	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-06-04	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-09-17	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-12-24	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-02-11	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/02/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2024-01-16	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2024-05-07	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2767 DE 16-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.